Chhattisgarh Forest Department

NWFP Certification


The Chief Executive Officer of the National Medicinal Plants Board explained to the august body some of the initiatives taken by the National Medicinal Plants Board. Some of them are enumerated below:

Dr. Rawat concluded that certification must be done as per international protocols and there should be quality control systems at every stage and the GAP, GCP and GMP should be followed. All these practices will ultimately lead to an opening gateway to international market.  

Presentation by Mr. G.A. Kinhal (IFS), Coordinator GEF and other special projects, Foundation for Revitalization of Local Health Traditions (FRLHT), Bangalore.

Mr. Kinhal made presentation titled "Regulatory Framework for Harvest and Trade in Wild Species of Medicinal Plants: Principles, design and Challenges". He told that the content aspect of harvesting is secondary, but composition is of prime concern. Hence there should be regulation to ensure that critically endangered species are not taken out from the forests without proper measures for conservation and propagation of the soecies. He suggested that certification shall proceed gradually from GMP based approach to GTP based systems. The current system of regulation is negative in nature and hence it undermines livelihood issues.  

He stated that around 90% of medicinal plants used by the Indian industries are collected from the wild. More than 70% of plant collections involve removal of plants for obtaining the parts. Currently 200 species of medicinal plants have been assessed as rare, endangered and threatened.  

Mr. Kinhal also pointed out towards the status of trade in medicinal plants. According to him, 880 species of medicinal plants are in All India Trade, out of which 88 species are from purely cultivated sources, 46 are imported and exotic and 212 are collected both from wild and from limited cultivation. The rest (534 species) are sourced purely from wild.

 Mr. Kinhal posed the question of the necessity to regulate trade in medicinal plants.

 He stated that regulations should ensure that –  

He stressed on the need for a positive regulatory regime to be instilled.

Mr. Kinhal presented a diagrammatic detail of the current scenario in medicinal plants sector.  

Please click on the following figures to move onto the respective page -

|1|

|2|

|3|

|4|

|5|

|6|

|7|

|8|

|9|

|10|

|11|

|12|

|13|

|14|

|15|

|16|

|17|

|18|

|19|

|20|

|21|

|22|

|23|

|24|

|25|

|26|

|27|

|28|

|29|

|30|

|31|

|32|

|33|

|34|

|35|

|36|

|37|

|38|

|39|

|40|

|41|

|42|

|43|

|44|

|45|

|46|

|47|

|48|

|49|

|50|

|51|

|52|

|53|

|54|